Effect of vitamin D on short-term prognosis of acute ischemic stroke

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220702055334N1

Enrollment

Registered

2022-07-11

Start date

2022-07-23

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke. Cerebral infarction

Interventions

Intervention 1: Intervention group: Intervention group patients up to 24 hours from the onset of symptoms in addition to standard treatments (including antiplatelet (aspirin 325 mg stat and 80 mg dail

Eligibility

Sex/Gender

All

Age

19 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age with acute ischemic stroke diagnosed by clinical examination and CT scan findings

Exclusion criteria

Exclusion criteria: Admission after 24 hours from the onset of symptoms NIHSS >15 at admission being treated with vitamin D (at least the last 3 months) Receive alteplase History of malignancy

Design outcomes

Primary

Measure	Time frame
Disability severity (MRS). Timepoint: At the beginning of the study, six weeks after the intervention. Method of measurement: MRS specific scoring system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezoo Jafarian Yazdi

Kashan University of Medical Sciences

Arezoo.jafarian1991@yahoo.com+98 21 2256 1168

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026